Where it is registered
Each register with its number of medicines and a few of them.
All medicines with Meningococcal conjugate vaccine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
19 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Menquadfi | United States | 0.5ML | Injection | Marketed | Sanofi Vaccines US Inc. |
| MenveoCombination | United States | 0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| MenveoCombination | United States | 0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| MenactraCombination | United States | 48UG/.5ML | For Injection | Marketed | Sanofi Vaccines US Inc. |
| Pedvaxhib | United States | 7.5UG/.5ML | Injection | Marketed | Merck Sharp & Dohme LLC |
| Menveo | European Union | Authorised | GSK Vaccines S.r.l. | ||
| Meningococcal Vaccine A&C VialCombination | Saudi Arabia | Authorised | Sanofi Pasteur | ||
| Meningococcal Vaccine A&C VialCombination | Saudi Arabia | Authorised | Sanofi Pasteur | ||
| MenQuadfi | European Union | Authorised | Sanofi Winthrop Industrie | ||
| Nimenrix | European Union | Authorised | Pfizer Europe MA EEIG | ||
| MenquadfiCombination | Canada | 10 MCG / 0.5 ML + 10 MCG / 0.5 ML + 10 MCG / 0.5 ML + 10 MCG / 0.5 ML + 55 MCG / 0.5 ML | Solution | Marketed | Sanofi Vaccines Canada LTD. |
| MenhibrixCombination | United States | 0.5ML | Injection | Withdrawn | GlaxoSmithKline Biologicals |
| ComvaxCombination | United States | 7.5UG PRP/125UG OMPC/5UG HBsAg | Injection | Withdrawn | Merck Sharp & Dohme LLC |
| MenQuadfiCombination | New Zealand | Inj 10 mcg of each meningococcal polysaccharide conjugated to a total of approximately 55 mcg of tetanus toxoid carrier per 0.5 ml vial | Funded | ||
| NimenrixCombination | New Zealand | Inj 5 mcg of each meningococcal polysaccharide conjugated to a total of approximately 44 mcg of tetanus toxoid carrier in 0.5 ml vial | Funded | ||
| NimenrixCombination | New Zealand | Inj 5 mcg of each meningococcal polysaccharide conjugated to a total of approximately 44 mcg of tetanus toxoid carrier per 0.5 ml vial | Funded | ||
| Procomvax | European Union | Cancelled | Sanofi Pasteur MSD, SNC | ||
| Penbraya | European Union | Withdrawn | Pfizer Europe MA EEIG | ||
| MenactraCombination | Canada | 4.0 MCG / 0.5 ML + 4.0 MCG / 0.5 ML + 4.0 MCG / 0.5 ML + 4.0 MCG / 0.5 ML | Solution | Cancelled | Sanofi Vaccines Canada LTD. |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
Sources
Compiled by Prognia from the public medicine registers of FDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 1
- Medicines
- 1
- Companies
- 1